FDA “Refuse-To-File” Decisions Encouraged For Incomplete, Poor NDAs – IG
This article was originally published in The Tan Sheet
Executive Summary
FDA should consider issuing "refuse-to-file" decisions more often for incomplete or inadequate NDAs, the HHS Inspector General recommended in a report released March 25